Latest Breaking News On - Valter pinto tim regan - Page 1 : vimarsana.com

Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results

Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofUnited statesAnne donohoePaul jarman nora popovaAnthony tennysonKevin lorenzValter pinto tim reganAwakn life sciencesInternational financial reporting standardsUs head of commercial developmentMultidisciplinary association for psychedelic studiesAwakn life sciences corpStrategic communicationsLicensing partnershipNewsfile corp

Awakn Life Sciences Corp : Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results

Toronto, Ontario (Newsfile Corp. - April 28, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and delivering combined

United kingdomCity ofUnited statesAnne donohoePaul jarman nora popovaAnthony tennysonKevin lorenzValter pinto tim reganAwakn life sciencesInternational financial reporting standardsUs head of commercial developmentMultidisciplinary association for psychedelic studiesAwakn life sciences corpStrategic communicationsLicensing partnershipNewsfile corp

Awakn Life Sciences Corp : Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

Toronto, Ontario (Newsfile Corp. - April 13, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and delivering revolutionary

United statesUnited kingdomAnne donohoeCelia morganBen sessaLinkedin facebookValter pinto tim reganPaul jarman nora popovaLaurie higbedJames collinsAwakn life sciencesStrategic communicationsNewsfile corpAwakn life sciences corpResearch developmentLife sciences

Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

Awakn Life Sciences Corp. , a biotechnology company, researching, developing, and delivering revolutionary therapeutics to treat addiction, today is providing shareholders with a business update on. | April 13, 2022

United statesUnited kingdomAnne donohoeCelia morganBen sessaLinkedin facebookValter pinto tim reganPaul jarman nora popovaLaurie higbedJames collinsAwakn life sciencesStrategic communicationsNewsfile corpAwakn life sciences corpResearch developmentLife sciences

Awakn Life Sciences Corp : Awakn Successfully Completes Phase One of Its Drug Discovery Program

Two Chemical Series Identified to Facilitate Lead Optimisation Activities Toronto, Ontario (Newsfile Corp. - April 6, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn')

United statesAnne donohoeDavid nuttPaul jarman nora popovaLinkedin facebookValter pinto tim reganAwakn life sciencesStrategic communicationsNewsfile corpNutt equasy enterprisesAwakn life sciences corpTwo chemical series identifiedFacilitate lead optimisationLife sciencesChief research officerEquasy enterprises